Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details Narrative)

v3.21.2
Related Party Transactions (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 13 Months Ended
Oct. 31, 2021
Feb. 28, 2021
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2019
Jan. 23, 2021
Dec. 31, 2020
Related Party Transaction [Line Items]                  
Prepaid expenses and other current asset     $ 878,243   $ 878,243       $ 841,958
Research and development expense     780,153 $ 573,061 1,934,432 $ 1,240,612      
Research expense accrued     $ 873,010   873,010       609,532
Pharmsynthez [Member]                  
Related Party Transaction [Line Items]                  
Monthly principal payments   $ 25,000           $ 25,000  
Loan extension fees         $ 12,500        
Pharmsynthez [Member] | Subsequent Event [Member]                  
Related Party Transaction [Line Items]                  
Monthly principal payments $ 25,000                
Pharmsynthez [Member] | Co Development Agreement [Member]                  
Related Party Transaction [Line Items]                  
Payment for note receivable             $ 500,000    
Note receivable interest rate     10.00%   10.00%        
Interest income     $ 12,000 13,000 $ 35,000 38,000      
Pharmsynthez [Member] | Sponsored Research Agreement [Member]                  
Related Party Transaction [Line Items]                  
Prepaid expenses and other current asset                 100,000
Payment for research agreement             $ 350,000    
Research and development expense     0 $ 0 100,000 $ 200,000      
Advanced payment                 25,000
Pharmsynthez [Member] | Sponsored Research Agreement [Member] | Prepaid Expenses And Other [Member]                  
Related Party Transaction [Line Items]                  
Prepaid expenses and other current asset     400,000   400,000       $ 500,000
Research expense accrued     $ 40,000   $ 40,000